Cite
Bronchodilator efficacy of tiotropium/formoterol (18/12 µg once daily via a Discair inhaler), tiotropium alone (18 µg by Handihaler) or combined with formoterol (12 µg twice daily by Aerolizer) in adults with moderate-to-severe stable COPD.
MLA
Yildiz, Birsen Pinar, et al. “Bronchodilator Efficacy of Tiotropium/Formoterol (18/12 Μg Once Daily via a Discair Inhaler), Tiotropium Alone (18 Μg by Handihaler) or Combined with Formoterol (12 Μg Twice Daily by Aerolizer) in Adults with Moderate-to-Severe Stable COPD.” Current Medical Research and Opinion, vol. 35, no. 12, Dec. 2019, pp. 2187–96. EBSCOhost, https://doi.org/10.1080/03007995.2019.1654722.
APA
Yildiz, B. P., Bayraktaroglu, M., & Gunen, H. (2019). Bronchodilator efficacy of tiotropium/formoterol (18/12 µg once daily via a Discair inhaler), tiotropium alone (18 µg by Handihaler) or combined with formoterol (12 µg twice daily by Aerolizer) in adults with moderate-to-severe stable COPD. Current Medical Research and Opinion, 35(12), 2187–2196. https://doi.org/10.1080/03007995.2019.1654722
Chicago
Yildiz, Birsen Pinar, Mesut Bayraktaroglu, and Hakan Gunen. 2019. “Bronchodilator Efficacy of Tiotropium/Formoterol (18/12 Μg Once Daily via a Discair Inhaler), Tiotropium Alone (18 Μg by Handihaler) or Combined with Formoterol (12 Μg Twice Daily by Aerolizer) in Adults with Moderate-to-Severe Stable COPD.” Current Medical Research and Opinion 35 (12): 2187–96. doi:10.1080/03007995.2019.1654722.